Design and implementation of a robot-assisted rehabilitation system, RehabRoby
Is this your thesis?
This record came from a bulk archive import. If it’s yours, link it to your profile.
2011
0 views
0 downloads
Abstract (EN)
In recent years, robot-assisted rehabilitation systems have become an active research area to quantitatively monitor and adapt to patient progress, and to ensure consistency during the rehabilitation. In this thesis, an exoskeleton type robot-assisted rehabilitation system called RehabRoby is developed for upper extremity rehabilitation purposes. A control architecture, which contains a high-level controller and a low-level controller, is designed for RehabRoby to complete the rehabilitation task in a desired and safe manner. A hybrid system modeling technique is used for high-level controller. An admittance control with inner robust position control loop is used for the low-level control of RehabRoby. Real-time experiments are performed with healthy subjects to evaluate control architecture of the robot-assisted rehabilitation system RehabRoby. Furthermore, usability of RehabRoby has been evaluated during the execution of rehabilitation tasks.
Author
Fatih Özkul
Institution
How to Cite
Fatih Özkul (Master Thesis). Design and implementation of a robot-assisted rehabilitation system, RehabRoby, 2011, Yeditepe University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Yeditepe University
- Studies on cyclodextrin complexation of a poorly water soluble anti-hyperlipidemic drug, tablet formulation and characterization(2021)
- Washington ambassadors in Turkish-US relations (1927-1960)(2023)
- Metamorphosis of female voices: A study of the violation of women in Greek and Roman mythology and feminist rewritings reclaiming the narrative(2022)
- Knowledge distillation with foundation models for image segmentation(2023)
- The relationship between machiavelism, grandiose and vulnerable narcissism, and loneliness among white collar workers(2023)
- Evaluation of drug-drug interaction checkers along clinically relevant adverse drug events in oncology and hematology pediatric patients(2023)